Inhibition of mycobacteria proliferation in macrophages by low cisplatin concentration through phosphorylated p53-related apoptosis pathway
Open Access
- 31 January 2023
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (1) , e0281170
Abstract
Background: Drug resistance is a prominent problem in the treatment of tuberculosis, so it is urgent to develop new anti- tuberculosis drugs. Here, we investigated the effects and mechanisms of cisplatin (DDP) on intracellular Mycobacterium smegmatis to tap the therapeutic potential of DDP in mycobacterial infection. Results: Macrophages infected with Mycobacterium smegmatis were treated with DDP alone or combined with isoniazid or rifampicin. The results showed that the bacterial count in macrophages decreased significantly after DDP (≤ 6 μg/mL) treatment. When isoniazid or rifampicin was combined with DDP, the number of intracellular mycobacteria was also significantly lower than that of isoniazid or rifampicin alone. Apoptosis of infected cells increased after 24 h of DDP treatment, as shown by flow cytometry and transmission electron microscopy detection. Transcriptome sequencing showed that there were 1161 upregulated and 645 downregulated differentially expressed genes (DEGs) between the control group and DDP treatment group. A Trp53-centered protein interaction network was found based on the top 100 significant DEGs through STRING and Cytoscape software. The expression of phosphorylated p53, Bax, JAK, p38 MAPK and PI3K increased after DDP treatment, as shown by Western blot analysis. Inhibitors of JAK, PI3K or p38 MAPK inhibited the increase in cell apoptosis and the reduction in the intracellular bacterial count induced by DDP. The p53 promoter Kevetrin hydrochloride scavenges intracellular mycobacteria. If combined with DDP, Kevetrin hydrochloride could increase the effect of DDP on the elimination of intracellular mycobacteria. In conclusion, DDP at low concentrations could activate the JAK, p38 MAPK and PI3K pathways in infected macrophages, promote the phosphorylation of p53 protein, and increase the ratio of Bax to Bcl-2, leading to cell apoptosis, thus eliminating intracellular bacteria and reducing the spread of mycobacteria. Conclusion: DDP may be a new host-directed therapy for tuberculosis treatment, as well as the p53 promoter Kevetrin hydrochloride.Keywords
Funding Information
- Chongqing Municipal Science and Technology Bureau (no. cstc2017jcyjAX0409)
- CQMU Program for Youth Innovation in Future Medicine (W0091)
This publication has 79 references indexed in Scilit:
- Suppression of Host p53 Is Critical for Plasmodium Liver-Stage InfectionCell Reports, 2013
- Apoptosis is an innate defense function of macrophages against Mycobacterium tuberculosisMucosal Immunology, 2011
- Infection of Human Coronary Artery Endothelial Cells by Group B Streptococcus Contributes to Dysregulation of Apoptosis, Hemostasis, and Innate Immune ResponsesMediators of Inflammation, 2011
- Mycobacterium tuberculosis-Induced Expression of Leukotactin-1 Is Mediated by the PI3-K/PDK1/Akt Signaling PathwayMolecules and Cells, 2010
- Cisplatin-Based Combination Chemotherapy for Advanced Hepatocellular Carcinoma: A Single Center Experience before the Sorafenib EraCancer Research and Treatment, 2010
- Leishmania infection inhibits cycloheximide-induced macrophage apoptosis in a strain-dependent mannerExperimental Parasitology, 2009
- Platinum(II) and Palladium(II) Complexes of Pyridine-2-Carbaldehyde Thiosemicarbazone as Alternative Antiherpes Simplex Virus AgentsBioinorganic Chemistry and Applications, 2007
- Induction of apoptosis limits cytomegalovirus cross‐species infectionThe EMBO Journal, 2006
- Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespanNature, 2003
- Platinum(IV) Complexes with Dipeptide. X-ray Crystal Structure, 195Pt NMR Spectra, and Their Inhibitory Glucose Metabolism Activity in Candida albicansInorganic Chemistry, 2001